Blood Tests During Menopause: Hormones, Bone Health, and Metabolic Changes
Menopause triggers significant hormonal and metabolic shifts. FSH, estradiol, lipids, thyroid function, and bone markers all change. This guide explains what to test during perimenopause and menopause, and what the results mean for your health.
Upload your blood test PDF and get a free scored health breakdown.
Get My Score →Why Blood Tests Change During Menopause
As ovarian function declines in perimenopause and stops in menopause, estrogen and progesterone fall dramatically. These hormones influence cholesterol metabolism, bone density, cardiovascular risk, thyroid function, insulin sensitivity, and inflammation. The blood test picture often changes substantially — and those changes carry long-term health implications worth monitoring.
Key Tests and What They Show
| Test | What Changes in Menopause |
|---|---|
| FSH (follicle-stimulating hormone) | Rises above 30–40 mIU/mL in menopause — confirms menopausal status when combined with symptoms and missed periods for 12 months |
| Estradiol (E2) | Falls below 30 pg/mL — low estradiol confirms ovarian quiescence |
| LDL cholesterol | Rises by an average of 10–15 mg/dL post-menopause as estrogen no longer suppresses LDL production |
| Triglycerides | Often increase; cardiovascular risk rises significantly post-menopause |
| TSH | |
| Fasting glucose/HbA1c | Insulin sensitivity decreases post-menopause; risk of type 2 diabetes increases |
| Calcium and vitamin D | Bone resorption accelerates; assess status and supplement if deficient |
Key Hormonal Markers in Perimenopause
Lipids and Cardiovascular Risk Post-Menopause
Before menopause, women have significantly lower cardiovascular risk than age-matched men — largely due to estrogen's protective effects on lipids and vascular function. After menopause, this protection disappears. LDL rises, HDL may fall slightly, triglycerides often increase, and the lipid ratio deteriorates. Within 10 years of menopause, women's cardiovascular risk converges with men's of the same age. Annual lipid panel monitoring post-menopause, with consideration of statin therapy based on 10-year cardiovascular risk calculation, is now standard practice in US preventive guidelines.
Bone Health Markers
Estrogen suppresses osteoclast activity (bone resorption). In the first 5 years after menopause, bone density can fall at 2–3% per year — far faster than at any other life stage. While DEXA scan (bone density X-ray) is the gold standard for assessing bone loss, blood markers provide supporting information: calcium (should be normal), vitamin D (25-OH vitamin D should be above 30 ng/mL for bone health), and occasionally bone resorption markers (CTX) to assess rate of bone loss. All postmenopausal women should discuss calcium and vitamin D status with their doctor.
Symptoms That Prompt Hormone Testing in Women 40–55
Does HRT Affect Blood Tests?
Hormone replacement therapy (HRT) affects several blood markers. Oral estrogen raises triglycerides and SHBG; transdermal estrogen has a more neutral effect on triglycerides. Progesterone components affect lipids differently depending on the specific formulation. If you are on or considering HRT, your lipid panel results should be interpreted in the context of your current regimen. Regular monitoring — lipids, blood pressure, and liver function if oral HRT — is appropriate.
Medical Disclaimer
This article is for educational purposes only and does not constitute medical advice. Reference ranges, supplement dosages, and nutritional information mentioned are general educational guidance from published research—not personalised recommendations. Do not use this content to self-diagnose or self-treat any condition. Always consult a qualified healthcare provider before making any changes to your health regimen, medications, or supplements.
See exactly where your results stand
Upload your blood test PDF and get a free A–F score across all 6 health domains in seconds.
Analyze My Blood Test →